MedservRegis Management
Management criteria checks 2/4
MedservRegis' CEO is David O’Connor, appointed in Jun 2021, has a tenure of 4.42 years. total yearly compensation is €441.96K, comprised of 66.9% salary and 33.1% bonuses, including company stock and options. directly owns 28% of the company’s shares, worth €20.77M. The average tenure of the management team and the board of directors is 0.8 years and 4.4 years respectively.
Key information
David O’Connor
Chief executive officer
€442.0k
Total compensation
| CEO salary percentage | 66.95% |
| CEO tenure | 4.4yrs |
| CEO ownership | 28.0% |
| Management average tenure | less than a year |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price Jump
Nov 04
Is MedservRegis (MTSE:MDS) Using Too Much Debt?
Oct 26Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price Boost
Sep 20We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO Compensation
May 22MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Feb 26Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)
Jan 20Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price Jump
Nov 28Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?
Nov 22MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift Shares
Jan 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | €5m |
| Mar 31 2025 | n/a | n/a | €3m |
| Dec 31 2024 | €442k | €296k | €2m |
| Sep 30 2024 | n/a | n/a | €869k |
| Jun 30 2024 | n/a | n/a | -€128k |
| Mar 31 2024 | n/a | n/a | €477k |
| Dec 31 2023 | €313k | €249k | €1m |
| Sep 30 2023 | n/a | n/a | €2m |
| Jun 30 2023 | n/a | n/a | €3m |
| Mar 31 2023 | n/a | n/a | €2m |
| Dec 31 2022 | €281k | €199k | €577k |
| Sep 30 2022 | n/a | n/a | -€5m |
| Jun 30 2022 | n/a | n/a | -€10m |
| Mar 31 2022 | n/a | n/a | -€9m |
| Dec 31 2021 | n/a | n/a | -€8m |
| Jun 30 2021 | n/a | n/a | -€9m |
| Mar 31 2021 | n/a | n/a | -€9m |
| Dec 31 2020 | n/a | n/a | -€12m |
| Sep 30 2020 | n/a | n/a | -€10m |
| Jun 30 2020 | n/a | n/a | -€9m |
| Mar 31 2020 | n/a | n/a | -€10m |
| Dec 31 2019 | n/a | n/a | -€7m |
| Sep 30 2019 | n/a | n/a | €1m |
| Jun 30 2019 | n/a | n/a | €4m |
| Mar 31 2019 | n/a | n/a | €5m |
| Dec 31 2018 | €309k | €262k | €6m |
Compensation vs Market: David's total compensation ($USD513.66K) is above average for companies of similar size in the MT market ($USD307.71K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David O’Connor (62 yo)
Mr. David Sean O’Connor is Group Chief Executive Officer of Medserv p.l.c. from July 2021 and serves as Executive Chairman from September 2025 and served as its Executive Director until September 2025. Mr....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 4.4yrs | €441.96k | 28% € 20.8m | |
| Co-Chief Executive Officer & Executive Director | less than a year | €424.14k | no data | |
| Co-Chief Executive Officer & Executive Director | less than a year | €421.64k | no data | |
| Company Secretary | no data | €25.00k | no data | |
| Chief Commercial Officer | no data | no data | no data |
Experienced Management: MDS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 4.4yrs | €441.96k | 28% € 20.8m | |
| Co-Chief Executive Officer & Executive Director | 4.4yrs | €424.14k | no data | |
| Co-Chief Executive Officer & Executive Director | 4.4yrs | €421.64k | no data | |
| Company Secretary | 4.4yrs | €25.00k | no data | |
| Non-Executive Independent Director | 4.4yrs | €35.00k | no data | |
| Non-Executive Vice-Chairman | 4.4yrs | €50.00k | no data | |
| Non-Executive Independent Director | 4.1yrs | €25.00k | no data | |
| Non-Executive Independent Director | 3.3yrs | €20.00k | no data |
Experienced Board: MDS's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/15 11:31 |
| End of Day Share Price | 2025/10/29 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedservRegis p.l.c. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.